Particle.news
Download on the App Store

WADA Weighs Probe Into Ski-Jumping ‘Genital Injection’ Claims as FIS Says There’s No Evidence

Because hyaluronic acid is not prohibited, anti-doping officials require credible proof of performance enhancement before opening a case.

Overview

  • WADA’s Olivier Niggli said the agency would examine any information to determine if the alleged practice relates to doping, and president Witold Banka pledged to look into the issue during Milano–Cortina 2026.
  • FIS spokesperson Bruno Sassi rejected the reports as a wild rumor, saying there has been no indication or evidence that competitors used hyaluronic acid injections for advantage.
  • The claims trace to German tabloid Bild, which alleged some jumpers use hyaluronic acid or paraffin injections before 3D body scans to qualify for slightly larger competition suits.
  • Analyses cited by outlets including The Times and a Frontiers study indicate that about 2 centimeters of additional suit surface could produce roughly a 5% lift increase or around 5.8 meters more distance.
  • Medical experts quoted in coverage say temporary enlargement via such injections is technically feasible but carries health risks, and FIS has tightened controls since the 2025 Trondheim suit-tampering case with enhanced 3D scans, pre- and post-jump checks, and microchipped suits.